Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

Hagop M. Kantarjian*, Jorge Cortes, Susan O'Brien, Francis J. Giles, Maher Albitar, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Deborah A. Thomas, Debra Resta, Moshe Talpaz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

264 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds